These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26896637)

  • 21. Thermal Ablation of Colorectal Lung Metastases: Retrospective Comparison Among Laser-Induced Thermotherapy, Radiofrequency Ablation, and Microwave Ablation.
    Vogl TJ; Eckert R; Naguib NN; Beeres M; Gruber-Rouh T; Nour-Eldin NA
    AJR Am J Roentgenol; 2016 Dec; 207(6):1340-1349. PubMed ID: 27680945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases.
    Yamashita S; Odisio BC; Huang SY; Kopetz SE; Ahrar K; Chun YS; Conrad C; Aloia TA; Gupta S; Harmoush S; Hicks ME; Vauthey JN
    Eur J Surg Oncol; 2017 Jun; 43(6):1040-1049. PubMed ID: 28187878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of recurrence following selective intraoperative radiofrequency ablation as an adjunct to hepatic resection for colorectal liver metastases.
    Eltawil KM; Boame N; Mimeault R; Shabana W; Balaa FK; Jonker DJ; Asmis TR; Martel G
    J Surg Oncol; 2014 Nov; 110(6):734-8. PubMed ID: 24965163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pre-operative rate of growth of colorectal metastases in patients selected for liver resection does not influence post-operative disease-free survival.
    Wiggans MG; Shahtahmassebi G; Aroori S; Bowles MJ; Briggs C; Stell DA
    Eur J Surg Oncol; 2016 Mar; 42(3):426-32. PubMed ID: 26821736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of recurrence after ablation of colorectal cancer liver metastases.
    Kingham TP; Tanoue M; Eaton A; Rocha FG; Do R; Allen P; De Matteo RP; D'Angelica M; Fong Y; Jarnagin WR
    Ann Surg Oncol; 2012 Mar; 19(3):834-41. PubMed ID: 21879262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation of liver metastasis in patients with locally controlled pancreatic ductal adenocarcinoma.
    Park JB; Kim YH; Kim J; Chang HM; Kim TW; Kim SC; Kim PN; Han DJ
    J Vasc Interv Radiol; 2012 May; 23(5):635-41. PubMed ID: 22525021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation.
    Gleisner AL; Choti MA; Assumpcao L; Nathan H; Schulick RD; Pawlik TM
    Arch Surg; 2008 Dec; 143(12):1204-12. PubMed ID: 19075173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of CD133
    Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
    Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT versus MR guidance for radiofrequency ablation in patients with colorectal liver metastases: a 10-year follow-up favors MR guidance.
    Pereira PL; Siemou P; Rempp HJ; Hoffmann R; Hoffmann RT; Kettenbach J; Clasen S; Helmberger T
    Eur Radiol; 2024 Jul; 34(7):4663-4671. PubMed ID: 38041717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer.
    Sclafani F; Incarbone M; Rimassa L; Personeni N; Giordano L; Alloisio M; Santoro A
    J Thorac Cardiovasc Surg; 2013 Jan; 145(1):97-103. PubMed ID: 22939863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of clinical risk score for colorectal liver metastases resected in a contemporary multicenter cohort.
    Beamish P; Lemke M; Li J; Dixon E; Abraham MT; Hernandez-Alejandro R; Bennett S; Martel G; Karanicolas PJ;
    HPB (Oxford); 2017 Aug; 19(8):675-681. PubMed ID: 28495435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of microwave ablation for colorectal cancer liver metastases: a single center experience.
    Eng OS; Tsang AT; Moore D; Chen C; Narayanan S; Gannon CJ; August DA; Carpizo DR; Melstrom LG
    J Surg Oncol; 2015 Mar; 111(4):410-3. PubMed ID: 25557924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum D-dimer as a prognostic marker in patients undergoing radiofrequency ablation of colorectal liver metastasis.
    Tellioglu G; Agcaoglu O; Siperstein A; Berber E
    J Invest Surg; 2012 Oct; 25(5):295-300. PubMed ID: 23020269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
    Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
    Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
    White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
    Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates.
    Hamada A; Yamakado K; Nakatsuka A; Uraki J; Kashima M; Takaki H; Yamanaka T; Inoue Y; Kusunoki M; Takeda K
    Jpn J Radiol; 2012 Aug; 30(7):567-74. PubMed ID: 22664831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
    Abitabile P; Hartl U; Lange J; Maurer CA
    Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients.
    Jakobs TF; Hoffmann RT; Trumm C; Reiser MF; Helmberger TK
    Anticancer Res; 2006; 26(1B):671-80. PubMed ID: 16739337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous Radiofrequency Ablation of Colorectal Cancer Liver Metastases: Factors Affecting Outcomes--A 10-year Experience at a Single Center.
    Shady W; Petre EN; Gonen M; Erinjeri JP; Brown KT; Covey AM; Alago W; Durack JC; Maybody M; Brody LA; Siegelbaum RH; D'Angelica MI; Jarnagin WR; Solomon SB; Kemeny NE; Sofocleous CT
    Radiology; 2016 Feb; 278(2):601-11. PubMed ID: 26267832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.